EHA Library - The official digital education library of European Hematology Association (EHA)

'SHEFAA' AN ITP PATIENT ADVOCACY GROUP: AN EGYPTIAN SINGLE CENTER EXPERIENCE
Author(s): ,
Mervat Mattar
Affiliations:
Clinical hematology unit, internal medicine,Cairo university,Cairo,Egypt
Doaa El Demerdash
Affiliations:
Clinical hematology unit, internal medicine,Cairo university,Cairo,Egypt
EHA Library. El Demerdash D. 06/09/21; 324916; EP1195
Dr. Doaa El Demerdash
Dr. Doaa El Demerdash
Contributions
Abstract
Presentation during EHA2021: All e-poster presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: EP1195

Type: E-Poster Presentation

Session title: Quality of life, palliative care, ethics and health economics

Background

The patient is the main constant in the delivery of health care throughout the world, patient advocacy organizations play a critical role in increasing public awareness of a specific disease and in demanding improvement in approaches to treatment. Patients advocacy group also enables patients to make informed decisions about their disease and to be responsible members of the health care team. To do this, patients must be informed about their condition and their treatment options, and given the opportunity to express their understanding, values and beliefs. They must be given the time and encouragement to ask questions, raise concerns, and express their feelings about what is happening to them. 

Aims
We aimed to raise the awareness of Immune thrombocytopenia being not uncommon disease anymore

Methods

we targeted ITP patients as well as their families, friends and normal populations  through regular direct group meetings, webinars, telemedicine and Facebook page in order to increase the awareness of ITP, correct the wrong believes  about the disease which may leads to wrong behaviors.  

Results
Our patient advocacy group was initiated in 2017 by doing many patients regular meetings explaining disease in simple Arabic language in collaboration with different medical specialties like gynecology, nutrition and psychiatry teams, raising the awareness of the disease by celebrating the  ITP awareness month in September each year with patients and their families, also we became  part of ITP global group actively participating in their activities. We initiated Facebook campaign supported by Novartis pharama.   Our campaign  achieved in 4 months duration (from august 2020 to December 2020) 155.537 followers, with 673.157 post engagements, 78% of the followers were female (68% of them were between  25-45 years old), 126.031 were Egyptian followers but other followers were from middle east countries as Saudi Arabia, Libya, UAE, Kuwait, Algeria, Jordon and morocco. All information about ITP were discussed in native simple language especially  the nature of ITP, clinical pictures, diagnosis, goals for treatment, models of treatment,  potential difficulties in adherence to treatment and Plan how to overcome these difficulties Most interaction were noticed in posts about COVID19 and ITP especially vaccination issue. Regarding questions which were asked frequently; 'how to know that I have thrombocytopenia' 'what to do in pregnancy'  and 'what are the symptoms of ITP'. 

Conclusion

Patient–health professional relationships which are grounded in effective communication, trust, reciprocal information, mutual understanding and respect are a foundation, and even a prerequisite for effective and efficient care


 

Keyword(s): Immune thrombocytopenia (ITP), Patient

Presentation during EHA2021: All e-poster presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: EP1195

Type: E-Poster Presentation

Session title: Quality of life, palliative care, ethics and health economics

Background

The patient is the main constant in the delivery of health care throughout the world, patient advocacy organizations play a critical role in increasing public awareness of a specific disease and in demanding improvement in approaches to treatment. Patients advocacy group also enables patients to make informed decisions about their disease and to be responsible members of the health care team. To do this, patients must be informed about their condition and their treatment options, and given the opportunity to express their understanding, values and beliefs. They must be given the time and encouragement to ask questions, raise concerns, and express their feelings about what is happening to them. 

Aims
We aimed to raise the awareness of Immune thrombocytopenia being not uncommon disease anymore

Methods

we targeted ITP patients as well as their families, friends and normal populations  through regular direct group meetings, webinars, telemedicine and Facebook page in order to increase the awareness of ITP, correct the wrong believes  about the disease which may leads to wrong behaviors.  

Results
Our patient advocacy group was initiated in 2017 by doing many patients regular meetings explaining disease in simple Arabic language in collaboration with different medical specialties like gynecology, nutrition and psychiatry teams, raising the awareness of the disease by celebrating the  ITP awareness month in September each year with patients and their families, also we became  part of ITP global group actively participating in their activities. We initiated Facebook campaign supported by Novartis pharama.   Our campaign  achieved in 4 months duration (from august 2020 to December 2020) 155.537 followers, with 673.157 post engagements, 78% of the followers were female (68% of them were between  25-45 years old), 126.031 were Egyptian followers but other followers were from middle east countries as Saudi Arabia, Libya, UAE, Kuwait, Algeria, Jordon and morocco. All information about ITP were discussed in native simple language especially  the nature of ITP, clinical pictures, diagnosis, goals for treatment, models of treatment,  potential difficulties in adherence to treatment and Plan how to overcome these difficulties Most interaction were noticed in posts about COVID19 and ITP especially vaccination issue. Regarding questions which were asked frequently; 'how to know that I have thrombocytopenia' 'what to do in pregnancy'  and 'what are the symptoms of ITP'. 

Conclusion

Patient–health professional relationships which are grounded in effective communication, trust, reciprocal information, mutual understanding and respect are a foundation, and even a prerequisite for effective and efficient care


 

Keyword(s): Immune thrombocytopenia (ITP), Patient

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies